Capital BlueCross today announced that quantity limits enacted in July 2017 are showing promising results in combatting the opioid epidemic. Between the second and third quarter of 2017, the amount of opioid tablets dispensed to Capital BlueCross members decreased by 42-percent. The total amount of members using opioids was also reduced by 12-percent. We were able to accomplish this due to our close working relationships with our provider partners. ... |